|
|
Active Org.- |
|
Active Indication- |
Inactive Indication- |
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date11 Feb 1960 |
100 Clinical Results associated with NCC x VMAT2 x VAP-1
100 Translational Medicine associated with NCC x VMAT2 x VAP-1
0 Patents (Medical) associated with NCC x VMAT2 x VAP-1